PHVS
Pharvaris BVNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
Factor tilt: Anti-Quality Mid Cap
$30.02-2.82%
Close Oct 13, 2026
- Market cap
- $2.04B
- 1 month
- -22.7%
- 3 months
- -14.6%
- 1 year
- +36.6%
- 52-week range
- $20.96$38.86
- Dividend
- No dividends on record
- Short interest
- 4.6% of float2M shares · settled Sep 30, 2026 · +12.5% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if PHVS is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
42 top institutions tracked
as of 2026-Q2 (filed 2026-09-22)
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: bearish
Last trade: sell 19 days ago
Red flags: 0
Largest 13-F holders · Q2 2026
125 filers reported a long position in PHVS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| FMR LLC | $227M | 6.6M | +4.5% |
| GENERAL ATLANTIC, L.P. | $226.5M | 6.6M | -18.4% |
| Foresite Capital Management IV, LLC | $165.2M | 4.8M | Unchanged |
| venBio Partners LLC | $160.6M | 4.6M | +0.1% |
| VIKING GLOBAL INVESTORS LP | $126.3M | 3.7M | Unchanged |
| EQT Fund Management S.a r.l. | $118.4M | 3.4M | Unchanged |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $116.7M | 3.4M | +8% |
| Bain Capital Life Sciences Investors, LLC | $92.5M | 2.7M | Unchanged |
| WELLINGTON MANAGEMENT GROUP LLP | $82.7M | 2.4M | +12.9% |
| Polar Capital Holdings Plc | $80.4M | 2.3M | +197.9% |
Get the Full Analysis for PHVS
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.